Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemiaPierre Fenaux, Miguel Á. Sanz, H. Link et al.|Leukemia|2000Cited by 171
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyStéphane de Botton, Pierre Fenaux, Miguel Á. Sanz et al.|Leukemia|2005Cited by 161
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupCéline Callens, Sylvie Chevret, JM Cayuela et al.|Leukemia|2005Cited by 139
Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-<i>Trans</i>-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia GroupStéphane de Botton, Pierre Fenaux, A Fawaz et al.|Journal of Clinical Oncology|2004Cited by 135